Drugs / Biosynthetic Human Insulin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00736515 Comparator | Oct 2008 → Aug 2011 | type 2 diabetes mellitus | Servier (Tianjin) Pharmaceutical Co. LTD. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Biosynthetic Human Insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00736515 ↗ |
| Route | Subcutaneous | “Monotherapy of subcutaneous injection of Biosynthetic Human Insulin Injection twice daily (before breakfast and before dinner)” NCT00736515 ↗ |